Back to search

Article

Enhanced axonal Neuregulin-1 type-III signaling ameliorates disease severity in a CMT1B mouse model

2018-08-07

Abstract excerpt

<h4>ABSTRACT</h4> Charcot–Marie–Tooth neuropathies (CMTs) are a group of genetic disorders that affect the peripheral nervous system (PNS) with heterogeneous pathogenesis and no available treatment. Axonal Neuregulin 1 type III (Nrg1TIII) drives peripheral nerve myelination by activating downstream signaling pathways such as PI3K/Akt and MAPK/Erk that converge on master transcriptional regulators of myelin genes,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a0adbf3f-79f2-523b-acae-4cbdbfa7ccbb
DOI
10.1101/386730
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Enhanced axonal Neuregulin-1 type-III signaling ameliorates disease severity in a CMT1B mouse modelDOI 10.1101/386730
Select a neighboring publication to make it the new centre.